Randomized Multicenter Placebo-controlled Trial on the Effect of Adalumumab on Vascular Inflammation in Patient With Moderate to Severe Psoriasis
Phase of Trial: Phase IV
Latest Information Update: 11 Sep 2016
At a glance
- Drugs Adalimumab (Primary)
- Indications Atherosclerosis; Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Innovaderm Research
- 31 Aug 2018 Biomarkers information updated
- 22 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 27 Mar 2015 Planned End Date changed from 1 Feb 2015 to 1 Feb 2016 as reported by ClinicalTrials.gov record.